US
MX
Stimulate cell regeneration and achieve a better quality of life
They are cells that have the ability to regenerate any damaged tissue, improving its function regardless of age. For example, bone, cartilage, kidney, liver, nervous system, heart, pancreas, among others.
Mesenchymal stem cells (MSCs) have different mechanisms of action when they enter the bloodstream. MSCs adhere to the endothelium of those tissues in which the expression of cell adhesion molecules has been stimulated, favoring their diapedesis and migration to the site of injury, where they initiate the repair process.
Controlled replication to avoid neoplasms in patients.
Cells with ample regenerative capacity.
Pre-stimulated cells for various pathologies.
Cells derived from placenta and umbilical cord.
Native: Adjuvant in the treatment of various pathologies such as chronic degenerative diseases, autoimmune disorders, and chronic inflammatory processes. They can also be used in certain dermatocosmetic and rejuvenation procedures.
ACE-2: Coadjuvant in the treatment of active SARS-CoV-2 infection and acute respiratory distress syndrome (ARDS) secondary to COVID-19.
Renal Stabilizer: Adjuvant in the treatment of post-COVID-19 syndrome, renal injury (GFR >26 mL/min), hepatic steatosis, chronic asthma, Lyme disease, and chronic infections.
Metabolic: Adjuvant in the treatment of familial hypercholesterolemia and mixed dyslipidemias.
Metformin: Coadjuvant in the treatment of Diabetes Mellitus (DM) types I and II, osteoporosis, and osteoarthritis.
Metformin IA (intra-articular): Adjuvant in the treatment of fractures (applied directly to the area to be consolidated), partial ligament ruptures (applied directly to the affected ligament), tendinitis, chondromalacia, and osteoarthrosis.
Neuromodulators: Coadjuvant in the treatment of diabetic neuropathy, rheumatoid arthritis, lupus, stable asthma, and hepatic steatosis.
Immunoboost: Adjuvant in the treatment of immunosuppression, severe viral and bacterial infections, chronic infections, and sepsis.
Capilar + D: Coadjuvant in the treatment of androgenic alopecia.
Capilar + D is a treatment that combines mesenchymal stem cells (MSCs) with dutasteride to combat androgenetic alopecia. MSCs have the ability to regenerate tissues and promote hair follicle repair, while dutasteride acts as a potent 5α-reductase inhibitor, reducing dihydrotestosterone (DHT) levels, the hormone responsible for hair follicle miniaturization. This unique combination offers an effective solution to stop hair loss and stimulate its growth.
The treatment begins with the preparation of the patient by the treating doctor seven days in advance. During this period, the elixir (Power Serum) is administered intravenously, which is designed to regulate biological processes in the endothelial system. Subsequently, the cells process begins.
Once the treatment has begun, the patient begins to perceive positive effects from the cells. Among these immediate effects is regulation of the immune system, the production of exosomes that stimulate cellular communication and diapedesis, which is the passage of cells from blood vessels to tissues.
Healthy patients who wish to delay aging and patients with chronic degenerative diseases.
Because donor selection procedures are carried out and the donor is monitored during the gestation period. Subsequently, it is complemented with procedures such as PCR tests to ensure they are free from viruses and bacteria. Additionally, each cells treatment is accompanied by a quality certificate confirming the procedures performed.
With these cells, various diseases can also be treated, such as fractures, diseases of the nervous system, lupus, Lyme disease, high cholesterol levels, viral infections, androgenic alopecia, among others.
The doctor conducts all necessary studies to have a complete medical record of the patient. This facilitates a reliable treatment protocol, regulating the doses. In the very rare case of a cells overdose, the patient may experience symptoms such as fever, nausea, and/or diarrhea.
